RUA Life Sciences (LON:RUA) Reaches New 12-Month High – Still a Buy?

RUA Life Sciences plc (LON:RUAGet Free Report) shares reached a new 52-week high on Tuesday . The company traded as high as GBX 27 and last traded at GBX 25.30, with a volume of 1266824 shares trading hands. The stock had previously closed at GBX 24.50.

RUA Life Sciences Stock Up 1.1%

The stock has a market cap of £15.69 million, a P/E ratio of -2.61 and a beta of 0.95. The company has a current ratio of 4.64, a quick ratio of 7.32 and a debt-to-equity ratio of 18.95. The stock’s fifty day moving average price is GBX 20.56 and its 200 day moving average price is GBX 16.64.

RUA Life Sciences (LON:RUAGet Free Report) last posted its quarterly earnings data on Tuesday, June 30th. The company reported GBX (0.33) EPS for the quarter. RUA Life Sciences had a negative net margin of 3.26% and a negative return on equity of 2.03%.

RUA Life Sciences Company Profile

(Get Free Report)

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.

Further Reading

Receive News & Ratings for RUA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RUA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.